Status:
COMPLETED
Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel
Lead Sponsor:
University Hospital, Brest
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
Objectives: A prospective investigation of the effect of omeprazole, a proton pump inhibitor, on the anti-platelet action of clopidogrel. The main decision criterion will concern change in VASP prote...
Detailed Description
Preventing recurrence of thrombosis following angioplasty relies on dual-therapy associating the anti-platelet agents aspirin and clopidogrel. This regime is kept up for between 1 and 6 months, depend...
Eligibility Criteria
Inclusion
- patient with indication of aspirin and clopidogrel treatment
Exclusion
- patient\<18 years
- liver disease
- drug eluting stent
- gastrointestinal ulcus
- bleeding
- pregnancy
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2006
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00349661
Start Date
June 1 2006
End Date
December 1 2006
Last Update
August 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology
Brest, France, 29200